Array BioPharma (ARRY) Earnings Preview For Quarterly Earnings Release Date
Array BioPharma Inc. (NASDAQ:ARRY) is expected to report last fiscal quarter's results after the closing bell on January 30, 2012. Let's review how Array BioPharma has performed in recent quarters.. The company was founded in 1998 and is headquartered in Boulder, Colorado.
52 Week High: $3.41
52 Week Low: $1.58
Book Value: $-2.35
Float Short:   4.05%
On average, 8 analysts are expecting a drop of $-0.06 in earnings per share compared to last quarter's results of $-0.06. The reporting quarter's estimated mean earnings are $-0.12 per share . Analyst estimates range between $-0.19 and $-0.08 per share.
The stock has moved higher in price 13.79% in the last month, with a change from a year ago of -22.74%.
The stock is performing a little better than the overall market with a slight relative gain. When comparing to the S&P 500, the year to date difference is 2.30%.
Investors have been rewarded with an increase of year-over-year revenue. Revenue reported was $71.90 million for 2011 vs. $53.88 million for 2010. The bottom line has rising earnings year-over-year of $-56.32 million for 2011 vs. $-77.63 million for 2010.The company's earnings before interest and taxes are rising with an EBIT year-over-year of $-36.77 million for 2011 vs. $-64.05 million for 2010. Rising revenue along with rising earnings is a very good sign and what we want to see with our companies. Be sure to check the margins to make sure that the bottom line is keeping up with the top line.
Here is a look at the fiscal year revenue.
Here is the last few quarters to get an idea how well they perform compared to estimates
Reported earnings per share compared to the mean estimate. Differences are rounded.
The total short interest number of shares for ARRY
The number of days to cover short interest based on average daily trading volume for ARRY
Thank you for reading my article. Please also feel free to share your thoughts and comments.
I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the confirmed symbols from earnings.com that I believe to be of the most interest.
52 Week High: $3.41
52 Week Low: $1.58
Book Value: $-2.35
Float Short:   4.05%
On average, 8 analysts are expecting a drop of $-0.06 in earnings per share compared to last quarter's results of $-0.06. The reporting quarter's estimated mean earnings are $-0.12 per share . Analyst estimates range between $-0.19 and $-0.08 per share.
The stock has moved higher in price 13.79% in the last month, with a change from a year ago of -22.74%.
The stock is performing a little better than the overall market with a slight relative gain. When comparing to the S&P 500, the year to date difference is 2.30%.
Investors have been rewarded with an increase of year-over-year revenue. Revenue reported was $71.90 million for 2011 vs. $53.88 million for 2010. The bottom line has rising earnings year-over-year of $-56.32 million for 2011 vs. $-77.63 million for 2010.The company's earnings before interest and taxes are rising with an EBIT year-over-year of $-36.77 million for 2011 vs. $-64.05 million for 2010. Rising revenue along with rising earnings is a very good sign and what we want to see with our companies. Be sure to check the margins to make sure that the bottom line is keeping up with the top line.
Here is a look at the fiscal year revenue.
Here is the last few quarters to get an idea how well they perform compared to estimates
Reported earnings per share compared to the mean estimate. Differences are rounded.
The total short interest number of shares for ARRY
The number of days to cover short interest based on average daily trading volume for ARRY
Thank you for reading my article. Please also feel free to share your thoughts and comments.
I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the confirmed symbols from earnings.com that I believe to be of the most interest.
(NASDAQ:ARRY)
Array BioPharma Inc.
